Intriguingly, another recent study reported that two TCR variants of increased binding interactions for the WT1 self/tumor antigen compared to the wild-type TCR were safe and did not mediate autoimmune tissue infiltration or damage when transduced into peripheral CD8 T cells and transferred in vivo (97). The gene discussed is CD8A; the disease is neoplasm.